By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Roche is licensing technology from the Biodesign Institute at Arizona State University and the Columbia University Nanoscience Center for the development of a new DNA sequencing system, Roche and the Arizona Technology Enterprises announced today.

The technologies being licensed were developed by Stuart Lindsay at the Biodesign Institute and Colin Nuckolls from Columbia and include "specialized approaches" for DNA base sensing and reading.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.